SUBSCRIBE
SUBSCRIBE

Australia

Deakin University Research Finds Rogue Cells that Could Cause Spread of Breast Cancer
June 13, 2007
 · 
1 min read
Biotech Bay
Questioning Whether Age Discrimination Affects Pharma Recruitment (Personal View from Candidate)
May 31, 2007
 · 
1 min read
Biotech Bay
Managing Talent in Pharma, The Right Way
May 31, 2007
 · 
1 min read
Biotech Bay
Half of Employees Never Consider Leaving Pharmaceuticals and Medical Sector
May 31, 2007
 · 
1 min read
Aspirin ‘Cuts Pre-Eclampsia Risk’, University of Sydney Study Finds
May 17, 2007
 · 
1 min read
Australian Scientists Directly Target Cancer Cells
May 10, 2007
 · 
1 min read
Dads to Blame for Fat Kids
May 8, 2007
 · 
1 min read
Pharm Country
Columbia University Scientists Discover New Virus Responsible For Deaths of 3 Transplant Recipients From Single Donor In Victoria, Australia
April 27, 2007
 · 
1 min read
New Blood Test can Diagnose and Monitor Treatment of Parkinson’s Disease, University of Melbourne and Howard Florey Institute Scientists Find
April 26, 2007
 · 
1 min read
University of Alberta Research Uncovers the Significant Benefits of Remote Monitoring
April 23, 2007
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
 · 
16 min read
Press Releases
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
February 18, 2026
 · 
9 min read
Press Releases
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein (“s-KL”) Isoform of the Human Klotho Gene Sequence
February 18, 2026
 · 
4 min read
Press Releases
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
February 18, 2026
 · 
4 min read
Press Releases
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
February 18, 2026
 · 
10 min read
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
 · 
5 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
 · 
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
 · 
8 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Press Releases
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
February 5, 2026
 · 
2 min read
Press Releases
Telix Full Year Results 2025 Investor Webcast Notification
February 4, 2026
 · 
5 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
 · 
2 min read
Press Releases
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
 · 
6 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
 · 
3 min read
Press Releases
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
 · 
4 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
 · 
7 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
 · 
11 min read
Press Releases
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
February 1, 2026
 · 
12 min read
Load More